6-HYDROXYWARFARIN

Details

Stereochemistry	RACEMIC
Molecular Formula	C19H16O5
Molecular Weight	324.3273
Optical Activity	( + / - )
Defined Stereocenters	0 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

SMILES

CC(=O)CC(C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC(O)=C3

InChI

InChIKey=IQWPEJBUOJQPDE-UHFFFAOYSA-N

InChI=1S/C19H16O5/c1-11(20)9-14(12-5-3-2-4-6-12)17-18(22)15-10-13(21)7-8-16(15)24-19(17)23/h2-8,10,14,21-22H,9H2,1H3

HIDE SMILES / InChI

Approval Year

PubMed

Show entries

Title	Date	PubMed
Assessing cytochrome P450 and UDP-glucuronosyltransferase contributions to warfarin metabolism in humans.	2009 Jul	19408964
Hydroxywarfarin metabolites potently inhibit CYP2C9 metabolism of S-warfarin.	2010 May 17	20429590

Showing 1 to 2 of 2 entries

Previous1Next

Patents

Show entries

Name

Type

Language

6-HYDROXYWARFARIN

Common Name

English

6-HYDROXYWARFARIN, (RS)-

Common Name

English

6-HYDROXYWARFARIN, (±)-

Common Name

English

2H-1-BENZOPYRAN-2-ONE, 4,6-DIHYDROXY-3-(3-OXO-1-PHENYLBUTYL)-

Systematic Name

English

Showing 1 to 4 of 4 entries

Previous1Next

Show entries

Code System

Code

Type

Description

EPA CompTox

DTXSID50939073

PRIMARY

CAS

17834-02-5

PRIMARY

PUBCHEM

54682459

PRIMARY

FDA UNII

P25D26M0HK

PRIMARY

Showing 1 to 4 of 4 entries

Previous1Next

PARENT (METABOLITE INACTIVE)


					5Q7ZVV76EI

WARFARIN

PARENT (METABOLITE)


					09CC5J5C8A

WARFARIN, (R)-

SUBSTANCE RECORD


					P25D26M0HK

6-HYDROXYWARFARIN